{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:09:09Z","timestamp":1719976149327},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jad.2015.12.058","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T18:30:53Z","timestamp":1451500253000},"page":"137-143","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD"],"prefix":"10.1016","volume":"193","author":[{"given":"Susan G.","family":"Kornstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Gommoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changzheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2015.12.058_bib1","series-title":"Practice Guideline for the Treatment of Patients with Major Depressive Disorder","author":"APA","year":"2010"},{"key":"10.1016\/j.jad.2015.12.058_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"APA","year":"2013"},{"key":"10.1016\/j.jad.2015.12.058_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4088\/JCP.12m08197","article-title":"Efficacy and safety of levomilnacipran sustained release 40mg, 80mg, or 120mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study","volume":"74","author":"Asnis","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.12.058_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1503\/jpn.130040","article-title":"Levomilnacipran ER 40mg and 80mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study","volume":"39","author":"Bakish","year":"2014","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2015.12.058_bib5","article-title":"Impact of pretreatment with antidepressants on the efficacy of duloxetine in terms of mood symptoms and functioning: an analysis of 15 pooled major depressive disorder studies","volume":"16","author":"Barros","year":"2014","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jad.2015.12.058_bib6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/da.22073","article-title":"Major depressive disorder in vulnerable groups of older adults, their course and treatment, and psychiatric comorbidity","volume":"30","author":"Chou","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2015.12.058_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jad.2013.04.016","article-title":"Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder","volume":"150","author":"Dodd","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.12.058_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0006-3223(96)00440-4","article-title":"Major depressive subtypes and treatment response","volume":"42","author":"Fava","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.12.058_bib9","series-title":"Levomilnacipran Extended-release: Prescribing Information","author":"Forest","year":"2013"},{"key":"10.1016\/j.jad.2015.12.058_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2015.01.014","article-title":"Duration of untreated depression influences clinical outcomes and disability","volume":"175","author":"Ghio","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.12.058_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jad.2013.10.002","article-title":"Duration of untreated illness and outcomes in unipolar depression: a systematic review and meta-analysis","volume":"152\u2013154","author":"Ghio","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.12.058_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0447.2005.00633.x","article-title":"Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project","volume":"112","author":"Gilmer","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2015.12.058_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/21556660.2014.884505","article-title":"A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40\u2013120mg\/day) in patients with major depressive disorder","volume":"3","author":"Gommoll","year":"2014","journal-title":"J. Drug Assess."},{"key":"10.1016\/j.jad.2015.12.058_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2015.12.058_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2008.08.010","article-title":"Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome","volume":"99","author":"Howland","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2015.12.058_bib16","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.mehy.2013.09.016","article-title":"Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?","volume":"81","author":"Hunter","year":"2013","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.jad.2015.12.058_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S1092852912000375","article-title":"Clinical and pharmacologic perspectives on the treatment of major depressive disorder","volume":"16","author":"Jefferson","year":"2011","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2015.12.058_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/JCP.0b013e3181dcb594","article-title":"Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder","volume":"30","author":"Kornstein","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.058_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cpr.2009.01.005","article-title":"The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research","volume":"29","author":"McKnight","year":"2009","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2015.12.058_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.12.058_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1017\/S1092852914000273","article-title":"Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials","volume":"20","author":"Montgomery","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2015.12.058_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4088\/JCP.12m08141","article-title":"Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"74","author":"Montgomery","year":"2013","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.jad.2015.12.058_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/YIC.0b013e32832a8eb2","article-title":"Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?","volume":"24","author":"Montgomery","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.058_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4088\/JCP.14r09297","article-title":"The nature of placebo response in clinical studies of major depressive disorder","volume":"76","author":"Papakostas","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.12.058_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200609000-00007","article-title":"Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics","volume":"21","author":"Perahia","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.058_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1017\/S0033291711002170","article-title":"Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report","volume":"42","author":"Rush","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2015.12.058_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/JCP.0000000000000060","article-title":"A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder","volume":"34","author":"Sambunaris","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.058_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/YIC.0000000000000033","article-title":"Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials","volume":"29","author":"Sambunaris","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.jad.2015.12.058_bib29","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.058_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/YIC.0b013e3282f2b4d6","article-title":"Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale","volume":"23","author":"Sheehan","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.058_bib31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4088\/JCP.11m07043","article-title":"The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations","volume":"73","author":"Sung","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.12.058_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/jwh.2005.14.609","article-title":"Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions","volume":"14","author":"Thase","year":"2005","journal-title":"J. Women's Health"},{"key":"10.1016\/j.jad.2015.12.058_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.31887\/DCNS.2008.10.4\/mhtrivedi","article-title":"Treatment strategies to improve and sustain remission in major depressive disorder","volume":"10","author":"Trivedi","year":"2008","journal-title":"Dialogues Clin. Neurosci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715310624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715310624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T08:14:36Z","timestamp":1653984876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715310624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"alternative-id":["S0165032715310624"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.12.058","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.12.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}